68 related articles for article (PubMed ID: 1889912)
1. Reassessment of dapsone as a marker of acetylator phenotypes.
Wiggan EB; Dennis S; Reele SB; Luke DR
Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):262-8. PubMed ID: 1889912
[TBL] [Abstract][Full Text] [Related]
2. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
Raj PP; Aschhoff M; Lilly L; Balakrishnan S
Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
[TBL] [Abstract][Full Text] [Related]
3. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Bluhm RE; Adedoyin A; McCarver DG; Branch RA
Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665
[TBL] [Abstract][Full Text] [Related]
4. Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.
Najim RA; Farid YY; Samad TA; Shihab SA
East Mediterr Health J; 2005; 11(5-6):1003-8. PubMed ID: 16761671
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone.
Helton DR; Osborne DW; Pierson SK; Buonarati MH; Bethem RA
Drug Metab Dispos; 2000 Aug; 28(8):925-9. PubMed ID: 10901702
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of dapsone by human whole blood.
Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
Gawrońska-Szklarz B; Górnik W; Kutrzeba J; Wójcicki J; Zakrzewski J
Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):921-3. PubMed ID: 1284448
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis.
Thapar MM; Ashton M; Lindegårdh N; Bergqvist Y; Nivelius S; Johansson I; Björkman A
Eur J Clin Pharmacol; 2002 Apr; 58(1):19-27. PubMed ID: 11956669
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of trimetrexate and dapsone in AIDS patients with Pneumocystis carinii pneumonia.
Koda RT; Dubé MP; Li WY; Chatterjee DJ; Stansell JD; Sattler FR
J Clin Pharmacol; 1999 Mar; 39(3):268-74. PubMed ID: 10073326
[TBL] [Abstract][Full Text] [Related]
12. Acetylator phenotype in Iraqi patients with atopic dermatitis.
Najim RA; Al-Waiz MM; Al-Razzuqi RA
Dermatol Online J; 2006 Dec; 12(7):1. PubMed ID: 17459287
[TBL] [Abstract][Full Text] [Related]
13. Intra-adipose administration of monoacetyldapsone to healthy volunteers.
Pieters FA; Zuidema J
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):510-6. PubMed ID: 3819527
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.
Lammintausta K; Kangas L; Lammintausta R
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):159-63. PubMed ID: 447435
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
17. The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis.
Sanders SW; Zone JJ
Arzneimittelforschung; 1986; 36(1):146-9. PubMed ID: 3954818
[TBL] [Abstract][Full Text] [Related]
18. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
